Author: Hongzhou Lu; Jingwen Ai; Yinzhong Shen; Yang Li; Tao Li; Xian Zhou; Haocheng Zhang; Qiran Zhang; Yun Ling; Sheng Wang; Hongping Qu; Yuan Gao; Yingchuan Li; Kanglong Yu; Duming Zhu; Hecheng Zhu; Rui Tian; Mei Zeng; Qiang Li; Yuanlin Song; Xiangyang Li; Jinfu Xu; Jie Xu; Enqiang Mao; Bijie Hu; Xin Li; Lei Zhu; Wenhong Zhang
Title: A descriptive study of the impact of diseases control and prevention on the epidemics dynamics and clinical features of SARS-CoV-2 outbreak in Shanghai, lessons learned for metropolis epidemics prevention Document date: 2020_2_23
ID: dbzrd23n_63
Snippet: Our study has several limitations. First, as the epidemics has not ended yet, the 348 effect of the control measures cannot be fully evaluated. Second, as most patients are 349 still hospitalized at the time of manuscript submission, clinical outcome remains to be 350 seen. Third, we did not measure cytokines and viral loads, which may be related to 351 disease progression and severity. 352.....
Document: Our study has several limitations. First, as the epidemics has not ended yet, the 348 effect of the control measures cannot be fully evaluated. Second, as most patients are 349 still hospitalized at the time of manuscript submission, clinical outcome remains to be 350 seen. Third, we did not measure cytokines and viral loads, which may be related to 351 disease progression and severity. 352
Search related documents:
Co phrase search for related documents- clinical outcome and disease progression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- clinical outcome and epidemic end: 1
- clinical outcome and fully evaluate: 1
- clinical outcome and viral load: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- clinical outcome and viral load cytokine: 1, 2
- control measure and disease progression: 1, 2
- control measure and epidemic end: 1, 2, 3, 4
- control measure and viral load: 1, 2, 3, 4, 5, 6, 7, 8
- disease progression and epidemic end: 1, 2, 3, 4, 5, 6
- disease progression and fully evaluate: 1, 2, 3
- disease progression and manuscript submission: 1
- disease progression and manuscript submission time: 1
- disease progression and viral load: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
- disease progression and viral load cytokine: 1, 2, 3, 4
- epidemic end and viral load: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date